Tarsus Pharmaceuticals, Inc. (TARS) quarterly income statement — complete revenue, gross profit & net income history
Tarsus Pharmaceuticals, Inc. (TARS) annual income statement — 8-year revenue, gross profit & net income history
| Metric | Q3'26 | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 |
|---|
| Sales/Revenue | 194.57M | 173.91M | 162.05M | 151.67M | 118.7M | 102.66M | 78.33M | 66.41M | 48.12M | 40.81M | 27.61M | 13.08M | 1.87M | 0 | 2.5M | 10M | 0 | 15.28M | 539K | 338K |
| Revenue Growth % | 63.92% | 69.41% | 106.87% | 128.39% | 146.68% | 151.54% | 183.68% | 407.86% | 2471.78% | - | 1004.56% | 30.76% | - | -100% | 363.82% | 2858.58% | -100% | -30.61% | -98.39% | - |
| Cost of Goods Sold | 13.89M | 12.11M | 9.4M | 10.93M | 24.59M | 6.24M | 5.21M | 4.93M | 3.24M | 3M | 1.65M | 1.22M | 377K | 316K | 255K | 400K | 211K | 522K | 33K | -24K |
| COGS % of Revenue | 7.14% | 6.97% | 5.8% | 7.2% | 20.72% | 6.08% | 6.65% | 7.42% | 6.74% | 7.36% | 5.99% | 9.3% | 20.15% | - | 10.2% | 4% | - | 3.42% | 6.12% | -7.1% |
| Gross Profit | 180.68M | 161.8M | 152.66M | 140.74M | 94.1M | 96.42M | 73.12M | 61.48M | 44.88M | 37.81M | 25.96M | 11.86M | 1.49M | -316K | 2.25M | 9.6M | -211K | 14.76M | 506K | 362K |
| Gross Margin % | 92.86% | 93.03% | 94.2% | 92.8% | 79.28% | 93.92% | 93.35% | 92.58% | 93.26% | 92.64% | 94.01% | 90.7% | 79.85% | - | 89.8% | 96% | - | 96.58% | 93.88% | 107.1% |
| Gross Profit Growth % | 92% | 67.8% | 108.77% | 128.91% | 109.7% | 155.03% | 181.68% | 418.4% | 2903.75% | 12064.87% | 1056.35% | 23.54% | 808.06% | -102.14% | 343.68% | 2551.93% | -117.96% | -30.66% | -98.43% | - |
| Operating Expenses | 842.77M | 181.71M | 158.78M | 148.72M | 108.63M | 118.61M | 99.4M | 85.9M | 70.04M | 71.11M | 63.64M | 56.31M | 42.43M | 32.51M | 27.2M | 24.66M | 22.7M | 19.98M | 20.03M | 14.81M |
| OpEx % of Revenue | 433.15% | 104.48% | 97.98% | 98.05% | 91.52% | 115.53% | 126.9% | 129.36% | 145.55% | 174.24% | 230.48% | 430.64% | 2267.72% | - | 1087.88% | 246.61% | - | 130.78% | 3715.58% | 4381.66% |
| Selling, General & Admin | 168.02M | 150.7M | 136.43M | 130.68M | 108.63M | 103.01M | 85M | 69.03M | 57.91M | 58.79M | 51.58M | 43.01M | 30.32M | 19.96M | 14.84M | 14.63M | 11.78M | 10.38M | 7.95M | 6.77M |
| SG&A % of Revenue | 86.36% | 86.65% | 84.19% | 86.16% | 91.52% | 100.34% | 108.5% | 103.95% | 120.35% | 144.05% | 186.78% | 328.88% | 1620.74% | - | 593.64% | 146.33% | - | 67.92% | 1474.21% | 2003.55% |
| Research & Development | 44.19M | 31.01M | 22.35M | 18.04M | 16.28M | 15.59M | 14.41M | 16.87M | 12.13M | 12.32M | 12.07M | 13.3M | 12.11M | 12.55M | 12.36M | 10.03M | 10.91M | 9.6M | 12.08M | 8.04M |
| R&D % of Revenue | 22.71% | 17.83% | 13.79% | 11.89% | 13.72% | 15.19% | 18.39% | 25.41% | 25.2% | 30.18% | 43.7% | 101.75% | 646.98% | - | 494.24% | 100.28% | - | 62.86% | 2241.37% | 2378.11% |
| Other Operating Expenses | 1000K | 0 | 0 | 0 | -1000K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -662.09M | -19.91M | -6.12M | -7.98M | -14.53M | -22.18M | -26.28M | -24.42M | -25.16M | -33.3M | -37.68M | -44.45M | -40.94M | -32.82M | -24.95M | -15.06M | -22.91M | -5.22M | -19.52M | -14.45M |
| Operating Margin % | -340.29% | -11.45% | -3.78% | -5.26% | -12.24% | -21.61% | -33.55% | -36.77% | -52.29% | -81.6% | -136.47% | -339.94% | -2187.87% | - | -998.08% | -150.61% | - | -34.2% | -3621.71% | -4274.56% |
| Operating Income Growth % | -4457.05% | 10.26% | 76.7% | 67.34% | 42.26% | 33.39% | 30.26% | 45.06% | 38.53% | -1.47% | -51.03% | -195.13% | -78.71% | -528.27% | -27.82% | -4.24% | -45.85% | -171.74% | -282.2% | -25.89% |
| EBITDA | -661.07M | -18.91M | -5.68M | -7.53M | -14.13M | -21.73M | -25.82M | -23.99M | -24.88M | -33.06M | -37.41M | -44.1M | -40.69M | -32.64M | -24.85M | -14.96M | -22.81M | -5.13M | -19.48M | -14.41M |
| EBITDA Margin % | -339.76% | -10.87% | -3.51% | -4.97% | -11.9% | -21.17% | -32.96% | -36.12% | -51.7% | -81.01% | -135.49% | -337.28% | -2174.83% | - | -993.92% | -149.63% | - | -33.59% | -3614.1% | -4262.72% |
| EBITDA Growth % | -4578.8% | 12.99% | 77.98% | 68.6% | 43.21% | 34.27% | 30.99% | 45.61% | 38.86% | -1.3% | -50.57% | -194.75% | -78.38% | -535.99% | -27.56% | -3.85% | -46.02% | -168.88% | -280.02% | -25.98% |
| D&A (Non-Cash Add-back) | 1.03M | 1M | 437K | 443K | 400K | 453K | 460K | 432K | 284K | 239K | 270K | 347K | 244K | 182K | 104K | 98K | 94K | 92K | 41K | 40K |
| EBIT | -661.51M | -13.68M | -7.19M | -4.1M | -12.59M | -18.1M | -22.91M | -20.8M | -20.98M | -31.18M | -34.75M | -40.91M | -38.32M | -30.61M | -22.76M | -12.91M | -21.93M | -5.2M | -19.92M | -14.45M |
| Net Interest Income | 1.59M | 1.54M | 1.59M | 1.74M | 2M | 2.13M | 1.38M | 1.47M | 1.8M | 2.02M | 2.13M | 1.99M | 1.98M | 1.41M | 1.61M | 1.44M | 428K | -247K | -316K | 12K |
| Interest Income | 3.78M | 3.7M | 3.72M | 3.95M | 4.11M | 4.23M | 3.45M | 3.65M | 4.12M | 4.13M | 3.12M | 2.98M | 2.84M | 2.23M | 2.29M | 2.13M | 1.06M | 297K | 0 | 12K |
| Interest Expense | 2.19M | 2.16M | 2.13M | 2.21M | 2.12M | 2.09M | 2.07M | 2.17M | 2.32M | 2.11M | 983K | 989K | 858K | 815K | 684K | 692K | 633K | 544K | 316K | 0 |
| Other Income/Expense | -1.6M | 4.07M | -3.2M | 1.66M | 1.94M | 1.84M | 1.16M | 1.31M | 1.74M | 12K | 1.95M | 2.55M | 1.79M | 1.4M | 1.53M | 1.46M | 390K | -519K | -716K | -349K |
| Pretax Income | -663.69M | -15.84M | -9.32M | -6.31M | -12.59M | -20.34M | -25.12M | -23.11M | -23.42M | -33.29M | -35.73M | -41.9M | -39.15M | -31.42M | -23.42M | -13.6M | -22.52M | -5.74M | -20.24M | -14.8M |
| Pretax Margin % | -341.11% | -9.11% | -5.75% | -4.16% | -10.6% | -19.81% | -32.07% | -34.8% | -48.67% | -81.57% | -129.39% | -320.45% | -2092.36% | - | -936.76% | -135.99% | - | -37.59% | -3754.55% | -4377.81% |
| Income Tax | 4.64M | 2.72M | -2.35M | 2.06M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -5K | 0 | 1K | 54K |
| Effective Tax Rate % | -0.7% | -17.15% | 25.24% | -32.61% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0.02% | 0% | -0% | -0.36% |
| Net Income | -668.33M | -18.55M | -6.97M | -8.37M | -12.59M | -20.34M | -25.12M | -23.11M | -23.42M | -33.29M | -35.73M | -41.9M | -39.15M | -31.42M | -23.42M | -13.6M | -22.51M | -5.74M | -20.24M | -14.85M |
| Net Margin % | -343.49% | -10.67% | -4.3% | -5.52% | -10.6% | -19.81% | -32.07% | -34.8% | -48.67% | -81.57% | -129.39% | -320.45% | -2092.36% | - | -936.76% | -135.99% | - | -37.59% | -3754.73% | -4393.79% |
| Net Income Growth % | -5210.56% | 8.8% | 72.27% | 63.77% | 46.26% | 38.9% | 29.7% | 44.84% | 40.18% | -5.94% | -52.57% | -208.13% | -73.91% | -447.17% | -15.72% | 8.43% | -43.41% | -191.17% | -296.75% | -29.51% |
| Net Income (Continuing) | -668.33M | -18.55M | -6.97M | -8.37M | -12.59M | -20.34M | -25.12M | -23.11M | -23.42M | -33.29M | -35.73M | -41.9M | -39.15M | -31.42M | -23.42M | -13.6M | -22.51M | -5.74M | -20.24M | -14.85M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -14.40 | -0.43 | -0.16 | -0.20 | -0.30 | -0.48 | -0.64 | -0.60 | -0.61 | -0.88 | -1.01 | -1.31 | -1.28 | -1.17 | -0.88 | -0.53 | -0.84 | -0.24 | -0.98 | -0.72 |
| EPS Growth % | -4700% | 10.42% | 75% | 66.67% | 50.82% | 45.45% | 36.63% | 54.2% | 52.34% | 24.91% | -14.77% | -147.17% | -52.38% | -396.5% | 10.2% | 26.39% | -10.53% | -181.39% | -308.51% | -33.33% |
| EPS (Basic) | -14.40 | -0.43 | -0.16 | -0.20 | -0.30 | -0.48 | -0.64 | -0.60 | -0.61 | -0.88 | -1.01 | -1.31 | -1.28 | -1.17 | -0.88 | -0.53 | -0.84 | -0.24 | -0.98 | -0.72 |
| Diluted Shares Outstanding | 46.42M | 43.39M | 42.96M | 42.78M | 42.61M | 42.36M | 39.35M | 38.56M | 38.38M | 37.82M | 35.3M | 31.94M | 30.62M | 26.82M | 26.74M | 25.68M | 26.66M | 24.33M | 20.71M | 20.63M |
| Basic Shares Outstanding | 46.42M | 43.39M | 42.96M | 42.78M | 42.61M | 42.36M | 39.35M | 38.56M | 38.38M | 37.82M | 35.3M | 31.94M | 30.62M | 26.82M | 26.74M | 25.68M | 26.66M | 24.33M | 20.71M | 20.63M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |